Factors associated with lipid goal attainment among acute coronary syndrome patients

Siti-Zainora Mohd-Zulkefli1, Marhanis-Salihah Omar1, Adyani Md-Redzuan1

  • 1Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.

Insights

Achieving lipid goals is crucial for acute coronary syndrome (ACS) patients. Younger age, female sex, and higher patient knowledge predict better lipid profile attainment, while smoking is associated with poorer outcomes.

Area of Science:

  • Cardiology
  • Lipid Metabolism
  • Public Health

Background:

  • Acute coronary syndrome (ACS) has a high incidence, necessitating effective risk reduction strategies.
  • Lipid goal attainment is a key factor in preventing recurrent heart attacks in ACS patients.
  • Understanding factors influencing lipid goal attainment can optimize patient outcomes.

Purpose of the Study:

  • To determine lipid profile attainment in ACS patients.
  • To analyze the prescribing patterns of lipid-lowering therapy.
  • To identify factors associated with achieving lipid goals in ACS patients.

Main Methods:

  • A researcher-assisted, cross-sectional survey was conducted.
  • The study involved 101 ACS patients at a tertiary hospital cardiology clinic.
  • Data were collected between March and May 2015.

Main Results:

  • Only 15.8% of ACS patients achieved their target low-density lipoprotein cholesterol (LDL-C).
  • Younger age and higher patient knowledge scores predicted better LDL-C attainment.
  • Male sex, smoking, and higher knowledge scores were associated with high-density lipoprotein cholesterol attainment, while smoking predicted higher triglyceride levels.

Conclusions:

  • Younger age, female sex, and higher patient knowledge are positive predictors for lipid goal attainment in ACS.
  • Smoking status is a significant predictor for lipid profile levels, particularly triglycerides.
  • These findings highlight the importance of patient-specific factors in managing dyslipidemia post-ACS.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
562
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
386
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
798
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
376
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.7K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.5K